George Simeon 4
4 · CRISPR Therapeutics AG · Filed May 31, 2024
Insider Transaction Report
Form 4
George Simeon
Director
Transactions
- Award
Stock Option (Right to buy)
2024-05-30+13,000→ 13,000 totalExercise: $54.06Exp: 2034-05-30→ Common Shares (13,000 underlying)
Footnotes (1)
- [F1]Subject to continued service to the Company or any of its subsidiaries, the options will vest and become exercisable in 12 equal monthly installments on the final day of each succeeding calendar month occurring after the grant date provided that the first installment vests on May 31, 2024 and the last installment vests on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2025 Annual General Meeting of Shareholders.